New‐generation anticancer drugs and medication‐related osteonecrosis of the jaw (MRONJ): Late onset 3 years after ipilimumab endovenous administration with a possible role of targe...

por Guida, Agostino, Perri, Francesco, Ionna, Franco, Ascierto, Paolo A., Grimaldi, Antonio M.
Publicado en Clin Case Rep (2020)

Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use

por Ascierto, Paolo A, Simeone, Ester, Giannarelli, Diana, Grimaldi, Antonio M, Romano, Anna, Mozzillo, Nicola
Publicado 2012

PD-L1 inhibitors in the pipeline: Promise and progress

por Vanella, Vito, Festino, Lucia, Strudel, Martina, Simeone, Ester, Grimaldi, Antonio M., Ascierto, Paolo A.
Publicado en Oncoimmunology (2017)

Immunotherapy in metastatic melanoma: a novel scenario of new toxicities and their management

por Simeone, Ester, Grimaldi, Antonio M, Festino, Lucia, Trojaniello, Claudia, Vitale, Maria G, Vanella, Vito, Palla, Marco, Ascierto, Paolo A
Publicado en Melanoma Manag (2019)

Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab

por Morello, Silvana, Capone, Mariaelena, Sorrentino, Claudia, Giannarelli, Diana, Madonna, Gabriele, Mallardo, Domenico, Grimaldi, Antonio M., Pinto, Aldo, Ascierto, Paolo Antonio
Publicado en J Transl Med (2017)

The role of BRAF V600 mutation in melanoma

por Ascierto, Paolo A, Kirkwood, John M, Grob, Jean-Jacques, Simeone, Ester, Grimaldi, Antonio M, Maio, Michele, Palmieri, Giuseppe, Testori, Alessandro, Marincola, Francesco M, Mozzillo, Nicola
Publicado 2012

Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients

por Tallerico, Rossana, Cristiani, Costanza M, Capone, Mariaelena, Madonna, Gabriele, Mallardo, Domenico, Simeone, Ester, Dominijanni, Andrea, Grimaldi, Antonio M, Colucci, Francesco, Ascierto, Paolo A, Carbone, Ennio
Publicado en J Transl Med (2015)

Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations

por Ascierto, Paolo A., Capone, Mariaelena, Grimaldi, Antonio M., Mallardo, Domenico, Simeone, Ester, Madonna, Gabriele, Roder, Heinrich, Meyer, Krista, Asmellash, Senait, Oliveira, Carlos, Roder, Joanna, Grigorieva, Julia
Publicado en J Immunother Cancer (2019)

Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for clinical response biomarker identific...

por Hotson, Drew, Alvarado, Ryan, Conroy, Andrew, Putta, Santosh, Simeone, Ester, Esposito, Assunta, Capone, Mariaelena, Madonna, Gabriele, Grimaldi, Antonio M, Rosen, David, Liang, Spencer, Cesano, Alessandra, Ascierto, Paolo A, Hawtin, Rachael
Publicado 2013

PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab

por Madonna, Gabriele, Ballesteros-Merino, Carmen, Feng, Zipei, Bifulco, Carlo, Capone, Mariaelena, Giannarelli, Diana, Mallardo, Domenico, Simeone, Ester, Grimaldi, Antonio M., Caracò, Corrado, Botti, Gerardo, Fox, Bernard A., Ascierto, Paolo A.
Publicado en Oncoimmunology (2018)

The abscopal effect: efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg

por Grimaldi, Antonio M, Simeone, Ester, Giannarelli, Diana, Palla, Marco, Muto, Paolo, Falivene, Sara, Sandomenico, Fabio, Petrillo, Antonella, Curvietto, Marcello, Esposito, Assunta, Paone, Miriam, Caracò, Corrado, Ciliberto, Gennaro, Mozzillo, Nicola, Ascierto, Paolo A
Publicado 2013

Efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg

por Grimaldi, Antonio M, Simeone, Ester, Giannarelli, Diana, Muto, Paolo, Falivene, Sara, Sandomenico, Fabio, Petrillo, Antonella, Curvietto, Marcello, Esposito, Assunta, Paone, Miriam, Palla, Marco, Caracò, Corrado, Ciliberto, Gennaro, Mozzillo, Nicola, Ascierto, Paolo A
Publicado 2014

Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for response biomarker identification

por Hotson, Drew, Alvarado, Ryan, Conroy, Andy, Putta, Santosh, Simeone, Ester, Esposito, Assunta, Capone, Mariaelena, Madonna, Gabriele, Grimaldi, Antonio M, Rosen, David B, Liang, Spencer, Cesano, Alessandra, Cacciapuoti, Carmela, Ascierto, Paolo A, Hawtin, Rachael E
Publicado 2014

Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients

por Capone, Mariaelena, Fratangelo, Federica, Giannarelli, Diana, Sorrentino, Claudia, Turiello, Roberta, Zanotta, Serena, Galati, Domenico, Madonna, Gabriele, Tuffanelli, Marilena, Scarpato, Luigi, Grimaldi, Antonio M., Esposito, Assunta, Azzaro, Rosa, Pinto, Antonio, Cavalcanti, Ernesta, Pinto, Aldo, Morello, Silvana, Ascierto, Paolo A.
Publicado en J Transl Med (2020)

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy

por Grimaldi, Antonio M, Simeone, Ester, Giannarelli, Diana, Muto, Paolo, Falivene, Sara, Borzillo, Valentina, Giugliano, Francesca Maria, Sandomenico, Fabio, Petrillo, Antonella, Curvietto, Marcello, Esposito, Assunta, Paone, Miriam, Palla, Marco, Palmieri, Giuseppe, Caracò, Corrado, Ciliberto, Gennaro, Mozzillo, Nicola, Ascierto, Paolo A
Publicado 2014

Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy

por Mozzillo, Nicola, Simeone, Ester, Benedetto, Lucia, Curvietto, Marcello, Giannarelli, Diana, Gentilcore, Giusy, Camerlingo, Rosa, Capone, Mariaelena, Madonna, Gabriele, Festino, Lucia, Caracò, Corrado, Di Monta, Gianluca, Marone, Ugo, Di Marzo, Massimiliano, Grimaldi, Antonio M, Mori, Stefano, Ciliberto, Gennaro, Ascierto, Paolo A
Publicado en Oncoimmunology (2015)

A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation

por Simeone, Ester, Scognamiglio, Giosuè, Capone, Mariaelena, Giannarelli, Diana, Grimaldi, Antonio M., Mallardo, Domenico, Madonna, Gabriele, Curvietto, Marcello, Esposito, Assunta, Sandomenico, Fabio, Sabbatino, Francesco, Bayless, Nicholas L., Warren, Sarah, Ong, SuFey, Botti, Gerardo, Flaherty, Keith T., Ferrone, Soldano, Ascierto, Paolo A.
Publicado en J Transl Med (2021)

Ipilimumab and Stereotactic Radiosurgery with CyberKnife(®) System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience

por Borzillo, Valentina, Di Franco, Rossella, Giannarelli, Diana, Cammarota, Fabrizio, Scipilliti, Esmeralda, D’Ippolito, Emma, Petito, Angela, Serra, Marcello, Falivene, Sara, Grimaldi, Antonio M., Simeone, Ester, Festino, Lucia, Vanella, Vito, Trojaniello, Claudia, Vitale, Maria Grazia, Madonna, Gabriele, Ascierto, Paolo A., Muto, Paolo
Publicado en Cancers (Basel) (2021)

IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients

por Tallerico, Rossana, Cristiani, Costanza M., Staaf, Elina, Garofalo, Cinzia, Sottile, Rosa, Capone, Mariaelena, Pico de Coaña, Yago, Madonna, Gabriele, Palella, Eleonora, Wolodarski, Maria, Carannante, Valentina, Mallardo, Domenico, Simeone, Ester, Grimaldi, Antonio M., Johansson, Sofia, Frumento, Paolo, Gulletta, Elio, Anichini, Andrea, Colucci, Francesco, Ciliberto, Gennaro, Kiessling, Rolf, Kärre, Klas, Ascierto, Paolo A., Carbone, Ennio
Publicado en Oncoimmunology (2016)

FUTURE PERSPECTIVES IN MELANOMA RESEARCH. Meeting report from the “Melanoma Research: a bridge from Naples to the World. Napoli, December 5(th)–6 (th)2011”

por Ascierto, Paolo A, Grimaldi, Antonio M, Curti, Brendan, Faries, Mark B, Ferrone, Soldano, Flaherty, Keith, Fox, Bernard A, Gajewski, Thomas F, Gershenwald, Jeffrey E, Gogas, Helen, Grossmann, Kenneth, Hauschild, Axel, Hodi, F Stephen, Kefford, Richard, Kirkwood, John M, Leachmann, Sancy, Maio, Michele, Marais, Richard, Palmieri, Giuseppe, Morton, Donald L, Ribas, Antoni, Stroncek, David F, Stewart, Rodney, Wang, Ena, Mozzillo, Nicola, Marincola, Franco M
Publicado 2012